Recent Performance of Eupraxia Pharmaceuticals Inc (EPRX) Stock: A Closer Look

Ulysses Smith

Eupraxia Pharmaceuticals Inc [EPRX] stock prices are up 2.09% to $7.34 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The EPRX shares have gain 16.69% over the last week, with a monthly amount glided 18.39%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Eupraxia Pharmaceuticals Inc [NASDAQ: EPRX] stock has seen the most recent analyst activity on July 24, 2025, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $11. Previously, H.C. Wainwright started tracking the stock with Buy rating on June 26, 2025, and set its price target to $12. On June 16, 2025, Canaccord Genuity initiated with a Speculative Buy rating. Craig Hallum started tracking the stock assigning a Buy rating and suggested a price target of $12 on February 21, 2025. Rodman & Renshaw initiated its recommendation with a Buy and recommended $9 as its price target on November 14, 2024.

The stock price of Eupraxia Pharmaceuticals Inc [EPRX] has been fluctuating between $2.68 and $7.37 over the past year. Eupraxia Pharmaceuticals Inc [NASDAQ: EPRX] shares were valued at $7.34 at the most recent close of the market.

Analyzing the EPRX fundamentals

To continue investigating profitability, this company’s Return on Assets is posted at -1.37, Equity is -1.19 and Total Capital is -1.75. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.08 points at the first support level, and at 6.81 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.49, and for the 2nd resistance point, it is at 7.63.

Ratios To Look Out For

It’s worth pointing out that Eupraxia Pharmaceuticals Inc [NASDAQ:EPRX]’s Current Ratio is 23.98. Also, the Quick Ratio is 23.98, while the Cash Ratio stands at 7.55.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.